Girao Tiago

Chief Financial Officer at Immunovant, Inc. · on record since Apr 9, 2026
VP & Chief Financial Officer at CYTORI THERAPEUTICS, INC. · on record since Sep 4, 2014
Director at Landos Biopharma, Inc. · on record since Apr 12, 2021

Insider trading activity of Girao Tiago

Figures computed from official regulatory filings — methodology.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Company	Filed	Type	Qty	Price	Value · USD	Src
Immunovant, Inc.	Jun 26, 2026	ExerciseD	-10,000	0.00 USD	—	SEC
Immunovant, Inc.	Jun 26, 2026	Exercise	10,000	15.90 USD	—	SEC
Immunovant, Inc.	Jun 26, 2026	Sell	-10,000	38.46 USD	—	SEC
Immunovant, Inc.	Apr 24, 2026	Sell	-25,760	29.62 USD	$763K	SEC
Immunovant, Inc.	Apr 9, 2026	AwardD	94,002	0.00 USD	$0	SEC
Immunovant, Inc.	Apr 9, 2026	Award	64,968	0.00 USD	$0	SEC
Immunovant, Inc.	May 5, 2025	AwardD	293,505	0.00 USD	$0	SEC
Immunovant, Inc.	May 5, 2025	Award	208,388	0.00 USD	$0	SEC
Landos Biopharma, Inc.	May 23, 2024	OtherD	-1,800	—	—	SEC
Landos Biopharma, Inc.	May 23, 2024	OtherD	-1,800	—	—	SEC
Landos Biopharma, Inc.	May 23, 2024	OtherD	-1,800	—	—	SEC
Landos Biopharma, Inc.	May 24, 2023	AwardD	18,000	0.00 USD	$0	SEC
Landos Biopharma, Inc.	Jun 9, 2022	AwardD	18,000	0.00 USD	$0	SEC
Landos Biopharma, Inc.	May 18, 2022	AwardD	18,000	0.00 USD	$0	SEC
Landos Biopharma, Inc.	Apr 12, 2021	AwardD	36,000	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Jul 27, 2018	OtherD	1	—	—	SEC
CYTORI THERAPEUTICS, INC.	Jul 27, 2018	OtherD	1,050	—	—	SEC
CYTORI THERAPEUTICS, INC.	Jul 27, 2018	OtherD	-1	—	—	SEC
CYTORI THERAPEUTICS, INC.	Nov 29, 2017	OtherD	1,800	—	—	SEC
CYTORI THERAPEUTICS, INC.	Nov 29, 2017	OtherD	1	—	—	SEC
CYTORI THERAPEUTICS, INC.	Nov 29, 2017	OtherD	-1	—	—	SEC
CYTORI THERAPEUTICS, INC.	Mar 17, 2017	AwardD	31,100	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Mar 10, 2017	AwardD	42,000	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Jun 15, 2016	OtherD	-5,667	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Jun 15, 2016	Other	5,667	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Immunovant, Inc.	Jun 26, 2026	ExerciseD	-10,000	0.00 USD	—	SEC
Immunovant, Inc.	Jun 26, 2026	Exercise	10,000	15.90 USD	—	SEC
Immunovant, Inc.	Jun 26, 2026	Sell	-10,000	38.46 USD	—	SEC
Immunovant, Inc.	Apr 24, 2026	Sell	-25,760	29.62 USD	$763K	SEC
Immunovant, Inc.	Apr 9, 2026	AwardD	94,002	0.00 USD	$0	SEC
Immunovant, Inc.	Apr 9, 2026	Award	64,968	0.00 USD	$0	SEC
Immunovant, Inc.	May 5, 2025	AwardD	293,505	0.00 USD	$0	SEC
Immunovant, Inc.	May 5, 2025	Award	208,388	0.00 USD	$0	SEC
Landos Biopharma, Inc.	May 23, 2024	OtherD	-1,800	—	—	SEC
Landos Biopharma, Inc.	May 23, 2024	OtherD	-1,800	—	—	SEC
Landos Biopharma, Inc.	May 23, 2024	OtherD	-1,800	—	—	SEC
Landos Biopharma, Inc.	May 24, 2023	AwardD	18,000	0.00 USD	$0	SEC
Landos Biopharma, Inc.	Jun 9, 2022	AwardD	18,000	0.00 USD	$0	SEC
Landos Biopharma, Inc.	May 18, 2022	AwardD	18,000	0.00 USD	$0	SEC
Landos Biopharma, Inc.	Apr 12, 2021	AwardD	36,000	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Jul 27, 2018	OtherD	1	—	—	SEC
CYTORI THERAPEUTICS, INC.	Jul 27, 2018	OtherD	1,050	—	—	SEC
CYTORI THERAPEUTICS, INC.	Jul 27, 2018	OtherD	-1	—	—	SEC
CYTORI THERAPEUTICS, INC.	Nov 29, 2017	OtherD	1,800	—	—	SEC
CYTORI THERAPEUTICS, INC.	Nov 29, 2017	OtherD	1	—	—	SEC
CYTORI THERAPEUTICS, INC.	Nov 29, 2017	OtherD	-1	—	—	SEC
CYTORI THERAPEUTICS, INC.	Mar 17, 2017	AwardD	31,100	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Mar 10, 2017	AwardD	42,000	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Jun 15, 2016	OtherD	-5,667	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Jun 15, 2016	Other	5,667	—	—	SEC